Structure of IgG1 Fab fragment in complex with Biotincytidinamide Descriptor: MAB M33 FAB FRAGMENT, heavy chain, light chain, ... Authors: Dengl, S, Hoffmann, E, Grote, M, Wagner, C, Mundigl, O, Georg
Antibody-drug conjugates offers many advantages as a drug delivery platform that allows for highly specific targeting of cell types and genes. Ideally, testing the efficacy of these systems requires t
ARX788 is an anti-HER2 antibody drug conjugate (ADC) developed using Ambrx proprietary Engineered Precision Biologics technology. The manufacturing process of ARX788 has been optimized during the cour
The inadequate understanding of the structure–activity relationship (SAR) of glycosite-specific antibody–drug conjugates (ADCs) hinders its design and development. Herein, we revealed the systemic SAR
